Aled Williams

Aled Williams is a seasoned executive in the biotech and pharmaceutical industries, currently serving as Chief Business Officer at Aravax and as a Non-Executive Director at Destiny Pharma PLC. Aled previously held various leadership positions at companies such as Enthera Pharmaceuticals, Polyneuron Pharmaceuticals AG, and VectivBio, as well as in significant roles at Shire Pharmaceuticals, Bristol-Myers Squibb, and Pfizer Pharmaceuticals. Aled's educational background includes a BSc (Hons) in Microbiology and Biochemistry from the University of Reading, and a Post-Graduate Diploma in Management Studies from the University of South Wales. Throughout their career, Aled has demonstrated expertise in managing rare disease portfolios and driving commercial strategies on a global scale.